Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters











Publication year range
1.
Intern Med ; 63(8): 1157-1162, 2024 Apr 15.
Article in English | MEDLINE | ID: mdl-37612083

ABSTRACT

A 16-year-old boy presented with sudden left homonymous hemianopsia followed by right ocular and occipital pain. Arterial spin labeling (ASL), a non-contrast magnetic resonance imaging technique used to evaluate perfusion, showed a decrease in cerebral blood flow in the right occipital lobe. Three hours after admission, the patient experienced right homonymous hemianopsia and ocular-to-occipital pain on the contralateral side. ASL revealed a decreased cerebral blood flow in the left occipital lobe. We ultimately diagnosed the patient with first-time migraine with aura, in which cortical spreading depression was visualized as decreased cerebral blood flow using ASL.


Subject(s)
Migraine Disorders , Migraine with Aura , Male , Humans , Adolescent , Hemianopsia/etiology , Migraine with Aura/complications , Migraine with Aura/diagnostic imaging , Magnetic Resonance Imaging/methods , Cerebrovascular Circulation/physiology , Spin Labels , Pain
2.
J Atheroscler Thromb ; 30(12): 1917-1926, 2023 Dec 01.
Article in English | MEDLINE | ID: mdl-37344447

ABSTRACT

AIM: The aim of the present study was to clarify the association between the Janus kinase 2 (JAK2) V617F mutation and large cerebral artery disease (LCAD) in patients with myeloproliferative neoplasms (MPNs). METHODS: We retrospectively analysed patients diagnosed with MPNs between June 1992 and June 2022 who underwent brain magnetic resonance imaging. LCAD was defined as extracranial or intracranial large artery stenosis (≥ 50%) or occlusion on magnetic resonance angiography. RESULTS: A total of 86 patients (47 males; median age, 69 years old) were enrolled in this study. JAK2 V617F mutation was detected in 63 (73.3%) patients and LCAD in 35 (40.7%) patients. Univariate analysis showed that history of ischaemic stroke (LCAD, 62.9% vs. non-LCAD, 11.8%; P<0.001), JAK2 V617F mutation (91.4% vs. 60.8%, P=0.002), and age ≥ 60 years (85.7% vs. 60.8%, P=0.016) were significantly associated with LCAD. Multiple logistic regression analysis showed that, in addition to ischaemic stroke, age ≥ 60 years and diabetes mellitus, JAK2 V617F mutation (odds ratio 29.2, 95% confidence interval 1.2-709.8, P=0.038) was independently associated with LCAD. LCAD was frequently observed in the intracranial carotid (14/35, 40.0%) and middle cerebral (13/35, 37.1%) arteries. CONCLUSIONS: This study revealed a significant association between the JAK2 V617F mutation and LCAD in patients with MPNs. This suggests that the JAK2 V617F mutation may promote cerebrovascular atherosclerosis and could be very important in determining therapeutic strategies for patients with not only JAK2 V617F-mutated MPNs but also LCAD-related stroke.


Subject(s)
Brain Ischemia , Ischemic Stroke , Myeloproliferative Disorders , Neoplasms , Stroke , Aged , Humans , Male , Middle Aged , Brain Ischemia/complications , Ischemic Stroke/complications , Janus Kinase 2/genetics , Mutation , Myeloproliferative Disorders/complications , Myeloproliferative Disorders/genetics , Myeloproliferative Disorders/diagnosis , Neoplasms/complications , Retrospective Studies , Stroke/genetics , Stroke/complications , Female
3.
Thromb Haemost ; 122(3): 415-426, 2022 03.
Article in English | MEDLINE | ID: mdl-34077976

ABSTRACT

BACKGROUND: Thrombosis is a dynamic process, and a thrombus undergoes physical and biochemical changes that may alter its response to reperfusion therapy. This study assessed whether thrombus age influenced reperfusion quality and outcomes after mechanical thrombectomy for cerebral embolism. METHODS: We retrospectively evaluated 185 stroke patients and thrombi that were collected during mechanical thrombectomy at three stroke centers. Thrombi were pathologically classified as fresh or older based on their granulocytes' nuclear morphology and organization. Thrombus components were quantified, and the extent of NETosis (the process of neutrophil extracellular trap formation) was assessed using the density of citrullinated histone H3-positive cells. Baseline patient characteristics, thrombus features, endovascular procedures, and functional outcomes were compared according to thrombus age. RESULTS: Fresh thrombi were acquired from 43 patients, and older thrombi were acquired from 142 patients. Older thrombi had a lower erythrocyte content (p < 0.001) and higher extent of NETosis (p = 0.006). Restricted mean survival time analysis revealed that older thrombi were associated with longer puncture-to-reperfusion times (difference: 15.6 minutes longer for older thrombi, p = 0.002). This association remained significant even after adjustment for erythrocyte content and the extent of NETosis (adjusted difference: 10.8 minutes, 95% confidence interval [CI]: 0.6-21.1 minutes, p = 0.039). Compared with fresh thrombi, older thrombi required more device passes before reperfusion (p < 0.001) and were associated with poorer functional outcomes (adjusted common odds ratio: 0.49; 95% CI: 0.24-0.99). CONCLUSION: An older thrombus delays reperfusion after mechanical thrombectomy for ischemic stroke. Adding therapies targeting thrombus maturation may improve the efficacy of mechanical thrombectomy.


Subject(s)
Brain , Extracellular Traps/metabolism , Intracranial Embolism/surgery , Ischemic Stroke , Recovery of Function/physiology , Thrombectomy , Thrombosis , Aged , Brain/blood supply , Brain/pathology , Citrullination , Female , Histones/metabolism , Humans , Immunohistochemistry , Ischemic Stroke/etiology , Ischemic Stroke/metabolism , Ischemic Stroke/pathology , Ischemic Stroke/rehabilitation , Male , Outcome Assessment, Health Care , Reperfusion/methods , Thrombectomy/adverse effects , Thrombectomy/methods , Thrombectomy/rehabilitation , Thrombosis/complications , Thrombosis/metabolism , Thrombosis/pathology , Time Factors
4.
PLoS One ; 16(8): e0256170, 2021.
Article in English | MEDLINE | ID: mdl-34398910

ABSTRACT

Serum biomarkers are associated with hemorrhagic transformation and brain edema after cerebral infarction. However, whether serum biomarkers predict hemorrhagic transformation in large vessel occlusion stroke even after mechanical thrombectomy, which has become widely used, remains uncertain. In this prospective study, we enrolled patients with large vessel occlusion stroke in the anterior circulation. We analyzed 91 patients with serum samples obtained on admission. The levels of matrix metalloproteinase-9 (MMP-9), amyloid precursor protein (APP) 770, endothelin-1, S100B, and claudin-5 were measured. We examined the association between serum biomarkers and hemorrhagic transformation within one week. Fifty-four patients underwent mechanical thrombectomy, and 17 patients developed relevant hemorrhagic transformation (rHT, defined as hemorrhagic changes ≥ hemorrhagic infarction type 2). Neither MMP-9 (no rHT: 46 ± 48 vs. rHT: 15 ± 4 ng/mL, P = 0.30), APP770 (80 ± 31 vs. 85 ± 8 ng/mL, P = 0.53), endothelin-1 (7.0 ± 25.7 vs. 2.0 ± 2.1 pg/mL, P = 0.42), S100B (13 ± 42 vs. 12 ± 15 pg/mL, P = 0.97), nor claudin-5 (1.7 ± 2.3 vs. 1.9 ± 1.5 ng/mL, P = 0.68) levels on admission were associated with subsequent rHT. When limited to patients who underwent mechanical thrombectomy, the level of claudin-5 was higher in patients with rHT than in those without (1.2 ± 1.0 vs. 2.1 ± 1.7 ng/mL, P = 0.0181). APP770 levels were marginally higher in patients with a midline shift ≥ 5 mm than in those without (79 ± 29 vs. 97 ± 41 ng/mL, P = 0.084). The predictive role of serum biomarkers has to be reexamined in the mechanical thrombectomy era because some previously reported serum biomarkers may not predict hemorrhagic transformation, whereas the level of APP770 may be useful for predicting brain edema.


Subject(s)
Brain Edema/diagnosis , Cerebral Infarction/diagnosis , Cerebrovascular Disorders/diagnosis , Stroke/diagnosis , Thrombectomy/methods , Aged , Aged, 80 and over , Amyloid beta-Protein Precursor/blood , Amyloid beta-Protein Precursor/genetics , Biomarkers/blood , Brain Edema/genetics , Brain Edema/pathology , Brain Edema/surgery , Cerebral Infarction/genetics , Cerebral Infarction/pathology , Cerebral Infarction/surgery , Cerebrovascular Disorders/genetics , Cerebrovascular Disorders/pathology , Cerebrovascular Disorders/surgery , Claudin-5/blood , Claudin-5/genetics , Endothelin-1/blood , Endothelin-1/genetics , Female , Gene Expression , Humans , Male , Matrix Metalloproteinase 9/blood , Matrix Metalloproteinase 9/genetics , Predictive Value of Tests , Prospective Studies , S100 Calcium Binding Protein beta Subunit/blood , S100 Calcium Binding Protein beta Subunit/genetics , Stroke/genetics , Stroke/pathology , Stroke/surgery
5.
J Med Case Rep ; 15(1): 119, 2021 Mar 09.
Article in English | MEDLINE | ID: mdl-33685504

ABSTRACT

BACKGROUND: Isolated basilar artery dissection (IBAD) is a rare but important cause of ischemic stroke. Anti-thrombotic therapy is often used to treat IBAD-related ischemic stroke, but selected cases might need more aggressive treatment. There is no previous report of emergent stenting for IBAD-related ischemic stroke after intravenous thrombolysis. CASE PRESENTATION: A 53-year-old Japanese woman was admitted to our hospital with disturbance of consciousness, right hemiplegia, severe dysarthria, and total gaze paralysis. Brain magnetic resonance imaging revealed no ischemic lesion, but magnetic resonance angiography showed stenosis in the basilar artery. After initiation of intravenous thrombolysis, her neurological symptoms dramatically improved. Five hours later, however, her symptoms deteriorated again. Cerebral angiography showed IBAD. Emergent stenting was successfully performed. At 90 days after stroke onset, she had no significant disability, with a modified Rankin scale score of 1. CONCLUSIONS: Emergent stenting can be an effective treatment for patients with IBAD-related ischemic stroke who are resistant to IV-rtPA.


Subject(s)
Brain Ischemia , Ischemic Stroke , Stroke , Basilar Artery/diagnostic imaging , Brain Ischemia/complications , Brain Ischemia/diagnostic imaging , Brain Ischemia/drug therapy , Dissection , Female , Humans , Middle Aged , Stroke/diagnostic imaging , Stroke/drug therapy , Thrombolytic Therapy , Treatment Outcome
6.
J Neuroendovasc Ther ; 15(8): 546-553, 2021.
Article in English | MEDLINE | ID: mdl-37502769

ABSTRACT

Objective: We report three patients successfully treated by emergent transvenous thrombectomy for cerebral venous sinus thrombosis (CVST). Case Presentation: (Case 1) A 77-year-old man presented with vomiting, dizziness, and headache. CT revealed local subarachnoid hemorrhage (l-SAH), and angiography confirmed occlusion of the right transverse sigmoid sinus and superior sagittal sinus (SSS). Emergent transvenous aspiration thrombectomy using a Penumbra catheter (PC) resulted in effective reperfusion. (Case 2) A 60-year-old man developed disorientation, sensory aphasia, and right hemiparesis. MRI demonstrated extensive cerebral edema caused by venous congestion in both thalami, and angiography revealed poor opacification of the SSS, straight sinus, and bilateral transverse sinuses. Venous sinus flow was restored by catheter aspiration using a PC and topical infusion of urokinase (UK). (Case 3) A 19-year-old man developed a headache, numbness of the right upper limb, motor paralysis, and convulsions. CT revealed l-SAH and dense clot sign in the SSS. The SSS was poorly delineated on angiography. Thrombus aspiration using a PC and topical UK administration achieved partial recanalization. Conclusion: Transvenous aspiration thrombectomy using large lumen catheters for patients with CVST is effective and safe. In particular, this method may be a better option than anti-coagulation therapy alone for patients presenting with a severe neurological condition or intracranial hemorrhage.

7.
J Stroke Cerebrovasc Dis ; 29(2): 104540, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31810720

ABSTRACT

BACKGROUND AND AIM: Mechanical thrombectomy was demonstrated to be useful for acute ischemic stroke. However, whether it is beneficial for patients with poor prestroke conditions, such as older adults and those with low activity of daily living, is unclear. METHODS: A total of 134 patients who underwent mechanical thrombectomy in our hospital between April 2015 and January 2019 were retrospectively evaluated. Good outcome was defined as modified Rankin scale score of 0-2 at 90 days after stroke onset. Several factors were analyzed to assess their effects on clinical outcomes. RESULTS: At 90 days after stroke onset, 37.3% (50 of 134) of patients had a good outcome. Prestroke modified Rankin scale score was independently associated with a good outcome (odds ratio .39, 95% confidence interval .22-.67, P < .001). In patients with prestroke modified Rankin scale score 0-1, 55.4% (46 of 83) had a good outcome, and no significant difference in prognosis was found between patients aged less than 80 years and those aged greater than or equal to 80 years (P = .64). More than half the patients with prestroke modified Rankin scale score greater than or equal to 2 were graded as modified Rankin scale score 5-6 at 90 days regardless of age, which was significantly higher than those with prestroke modified Rankin scale score 0-1 (P < .001). CONCLUSIONS: Patients with prestroke modified Rankin scale score 0-1 are expected to have a good prognosis after mechanical thrombectomy even if aged greater than or equal to 80 years. Patients with prestroke modified Rankin scale score greater than or equal to 2 might have an extremely poor prognosis, and we should be more careful in selecting candidates for mechanical thrombectomy.


Subject(s)
Activities of Daily Living , Brain Ischemia/therapy , Stroke/therapy , Thrombectomy , Age Factors , Aged , Aged, 80 and over , Brain Ischemia/diagnosis , Brain Ischemia/physiopathology , Clinical Decision-Making , Disability Evaluation , Female , Health Status , Humans , Male , Patient Selection , Predictive Value of Tests , Retrospective Studies , Risk Assessment , Risk Factors , Stroke/diagnosis , Stroke/physiopathology , Thrombectomy/adverse effects , Time Factors , Treatment Outcome
8.
Cerebrovasc Dis Extra ; 9(3): 107-113, 2019.
Article in English | MEDLINE | ID: mdl-31563915

ABSTRACT

INTRODUCTION: Mechanical thrombectomy (MT) for acute ischemic stroke has become a standard therapy, and the recanalization rate has significantly improved. However, some cases of unsuccessful recanalization still occur. We aimed to clarify patient factors associated with unsuccessful recanalization after MT for acute ischemic stroke. METHODS: This was a single-center, retrospective study of 119 consecutive patients with anterior circulation acute ischemic stroke who underwent MT at our hospital between April 2015 and March 2019. Successful recanalization after MT was defined as modified Treatment in Cerebral Ischemia (mTICI) grade 2b or 3, and unsuccessful recanalization was defined as mTICI grades 0-2a. Several factors were analyzed to assess their effect on recanalization rates. RESULTS: Successful recanalization was achieved in 88 patients (73.9%). The univariate analysis showed that female sex (38.6 vs. 67.7%, p = 0.007), a history of hypertension (53.4 vs. 83.9%, p = 0.003), and a longer time from groin puncture to recanalization (median 75 vs. 124 min, p < 0.001) were significantly associated with unsuccessful recanalization. The multivariate analysis confirmed that female sex (OR 3.18; 95% CI 1.12-9.02, p = 0.030), a history of hypertension (OR 4.84; 95% CI 1.32-17.8, p = 0.018), M2-3 occlusion (OR 4.26; 95% CI 1.36-13.3, p = 0.013), and the time from groin puncture to recanalization (per 10-min increase, OR 1.22; 95% CI 1.09-1.37, p < 0.001) were independently associated with unsuccessful recanalization. CONCLUSION: Female sex and a history of hypertension might be predictors of unsuccessful recanalization after MT for anterior circulation acute ischemic stroke. Further studies are needed to fully evaluate predictors of recanalization.


Subject(s)
Brain Ischemia/therapy , Stroke/therapy , Thrombectomy/adverse effects , Aged , Aged, 80 and over , Brain Ischemia/diagnosis , Brain Ischemia/physiopathology , Female , Humans , Hypertension/diagnosis , Hypertension/physiopathology , Male , Retrospective Studies , Risk Factors , Sex Factors , Stroke/diagnosis , Stroke/physiopathology , Time Factors , Treatment Failure
9.
J Stroke Cerebrovasc Dis ; 28(6): e71-e72, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30898443

ABSTRACT

A 48-year-old woman spontaneously developed occipital pain, without any other neurological deficit. A brain magnetic resonance angiography showed narrowing, irregular dilatation, and aneurysmal formation in both the vertebral arteries (VA). According to these findings and the clinical course, we diagnosed the patient with spontaneous VA dissection. There was no finding suggesting cerebral infarction or subarachnoid hemorrhage. Three-dimensional T1-weighted magnetic resonance imaging performed 27 days after first onset of headache revealed a crescent-shaped high-intensity lesion in both the VA walls. These findings indicated that the lesions in both VAs were equally in the subacute phase. Follow-up three-dimensional T1-weighted imaging indicated that the high-intensity signals in both VAs disappeared at almost the same time. This case report presents imaging evidence showing that spontaneous dissection occurred simultaneously in both the VAs.


Subject(s)
Diffusion Magnetic Resonance Imaging/methods , Imaging, Three-Dimensional/methods , Vertebral Artery Dissection/diagnostic imaging , Vertebral Artery/diagnostic imaging , Cerebral Angiography/methods , Female , Humans , Magnetic Resonance Angiography , Middle Aged , Predictive Value of Tests
SELECTION OF CITATIONS
SEARCH DETAIL